FDA Requests Data on CBD and Other Cannabis-Derived Compounds

FDA Requests Data on CBD and Other Cannabis-Derived Compounds

Today, the U.S. Food and Drug Administration held a meeting to discuss its regulatory approach to products that contain cannabis and cannabis-derived compounds, including cannabidiol (CBD). Read more about what topics FDA expressed interest in receiving comments.

TXT Fox
txtfox1@gmail.com
No Comments

Sorry, the comment form is closed at this time.